In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

JJDC Strategy Emphasizes the J & the J

Executive Summary

Under the leadership of new president David Holveck, Johnson & Johnson Development Corp. is aligning its strategy more closely with the needs and wants of J&J's many companies.
Advertisement

Related Content

Biopharmaceuticals Beyond The Drug: Changing Pharma's Value Proposition
Biopharmaceuticals Beyond The Drug: Changing Pharma's Value Proposition
Corporate Venture Strikes Again: Biocartis Lands €30 million--And A Partnership
Red Script Ventures : Another addition to Johnson & Johnson's early stage R&D tool-box
Corporate Venture Takes Center Stage
GSK Puts Up (Another) Venture Fund
Corporate VC Adds a Business Development Flavor
Movetis Takes GI from J&J

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002928

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel